Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home NIV in COPD
NCT07198880Not yet recruiting
- Sponsor
- Assiut University
- Start
- Jan 2026
- Primary completion
- Jan 2027
01
Overview
Open-label trial (2 arms), sponsored by Assiut University. Primary endpoints: Arterial Partial Pressure of Carbon Dioxide at 1 year and Adherence to BiPAP therapy at 1 year. Planned start Jan 2026; status: not yet recruiting.
Beyond the preview
Go deeper on NCT07198880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07198880.